{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:52:18Z","timestamp":1761540738568},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.amjopharm.2006.09.006","type":"journal-article","created":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T13:58:15Z","timestamp":1161698295000},"page":"244-250","source":"Crossref","is-referenced-by-count":22,"title":["Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission"],"prefix":"10.1016","volume":"4","author":[{"given":"Hanne","family":"Mose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Riis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren Paaske","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reimar","family":"Wernich Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Toft S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2006.09.006_bib1","first-page":"1","article-title":"Acetylsalicylic acid 100 years-from empirical to evidence-based medicine","volume":"15","author":"Kampmann","year":"1998","journal-title":"Praktisk Laegemiddelinformation"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish Aspirin LowDose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events","volume":"338","year":"1991","journal-title":"Lancet."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy-1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis","volume":"321","author":"Derry","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib6","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2000.02248.x","article-title":"Risk of upper gastrointestinal bleeding associated with use of lowdose aspirin","volume":"95","author":"Sorensen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding","volume":"310","author":"Weil","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib8","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(96)01254-8","article-title":"Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product","volume":"348","author":"Kelly","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-1-1","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations","volume":"1","author":"de Abajo","year":"2001","journal-title":"BMC Clin Pharmacol."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJM199409153311107","article-title":"Bleeding peptic ulcer","volume":"331","author":"Laine","year":"1994","journal-title":"N Eugl J Med."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib11","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2125.1991.tb05616.x","article-title":"Aspirin-induced gastric mucosal damage: Prevention by enteric-coating and relation to prostaglandin synthesis","volume":"32","author":"Hawthorne","year":"1991","journal-title":"Br J Clin Pharuaacol"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(80)90282-2","article-title":"Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man","volume":"2","author":"Hoftiezer","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/bmj.311.6999.222","article-title":"Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage","volume":"311","author":"Rockall","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib15","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1572-0241.2003.07517.x","article-title":"Acute upper GI bleeding: Did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993\/1994 and 2000","volume":"98","author":"van Leerdam","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/bmj.315.7107.510","article-title":"Acute upper gastrointestinal haemorrhage in west of Scotland: Case ascertainment study","volume":"315","author":"Blatchford","year":"1997","journal-title":"BMJ."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/gut.38.3.316","article-title":"Risk assessment after acute upper gastrointestinal haemorrhage","volume":"38","author":"Rockall","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00042737-200402000-00009","article-title":"Changes in aetiology and clinical outcome of acute upper gastrointestinal bleeding during the last 15 years","volume":"16","author":"Thomopoulos","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.amjopharm.2006.09.006_bib19","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib20","first-page":"55","article-title":"Descriptive tools and analysis","volume":"45","author":"Capella","year":"1993","journal-title":"WHO Reg Publ Eur. Ser."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Cbronic Dis."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity. A critical review of available methods","volume":"56","author":"de Groot","year":"2003","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib24","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/archinte.162.19.2197","article-title":"Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events","volume":"162","author":"Weisman","year":"2002","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians' Health Study","volume":"321","year":"1989","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjopharm.2006.09.006_bib26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jclinepi.2003.10.013","article-title":"Case-fatality rates for myocardial infarction declined in Denmark and Sweden during 1987\u20131999","volume":"57","author":"Rasmussen","year":"2004","journal-title":"J Clin Epidemiol."}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154359460600050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154359460600050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T19:21:11Z","timestamp":1547234471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154359460600050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S154359460600050X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2006.09.006","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}